SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001628280-23-022129
Filing Date
2023-06-15
Accepted
2023-06-15 07:03:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 FWP zentalis-fwp61523.htm FWP 19046
2 zentalislogo.jpg GRAPHIC 82577
  Complete submission text file 0001628280-23-022129.txt   134206
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filed by) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-255769 | Film No.: 231015938
SIC: 2834 Pharmaceutical Preparations